Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 038364/0495 | |
| Pages: | 4 |
| | Recorded: | 04/25/2016 | | |
Attorney Dkt #: | 456055US99SD DMS |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
7
|
|
Patent #:
|
|
Issue Dt:
|
09/02/2008
|
Application #:
|
10517600
|
Filing Dt:
|
12/13/2004
|
Publication #:
|
|
Pub Dt:
|
04/12/2007
| | | | |
Title:
|
HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/27/2008
|
Application #:
|
10528360
|
Filing Dt:
|
03/18/2005
|
Publication #:
|
|
Pub Dt:
|
09/14/2006
| | | | |
Title:
|
WT1 SUBSTITUTION PEPIDES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/10/2011
|
Application #:
|
12095418
|
Filing Dt:
|
05/29/2008
|
Publication #:
|
|
Pub Dt:
|
03/11/2010
| | | | |
Title:
|
PEPTIDES COMPRISING AN EPITOPE OF THE WILMS TUMOR GENE PRODUCT
|
|
|
Patent #:
|
|
Issue Dt:
|
02/23/2010
|
Application #:
|
12142372
|
Filing Dt:
|
06/19/2008
|
Publication #:
|
|
Pub Dt:
|
04/16/2009
| | | | |
Title:
|
HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/14/2012
|
Application #:
|
12795187
|
Filing Dt:
|
06/07/2010
|
Publication #:
|
|
Pub Dt:
|
11/18/2010
| | | | |
Title:
|
DIMERIZED PEPTIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
11/05/2013
|
Application #:
|
13053996
|
Filing Dt:
|
03/22/2011
|
Publication #:
|
|
Pub Dt:
|
09/22/2011
| | | | |
Title:
|
METHOD FOR CANCER IMMUNOTHERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
03/01/2016
|
Application #:
|
14022413
|
Filing Dt:
|
09/10/2013
|
Publication #:
|
|
Pub Dt:
|
02/13/2014
| | | | |
Title:
|
METHOD FOR CANCER IMMUNOTHERAPY
|
|
Assignee
|
|
|
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU |
OSAKA-SHI, OSAKA, JAPAN 541-8524 |
|
Correspondence name and address
|
|
OBLON, ET AL.
|
|
1940 DUKE STREET
|
|
ALEXANDRIA, VA 22314
|
Search Results as of:
05/06/2024 03:27 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|